Message from Icon Oncology CEO on COVID-19
Three eminent international colleagues will be speaking at the 4th ICON Conference in August. Their presentations will be aligned with the aims for the conference: to marry evidence-based medicine with the realities faced in day-to-day practice, delivering a well-rounded viewpoint on ‘Real-World Oncology’.
The upcoming ICON conference that will be held in Johannesburg on 12 – 14 August 2016 will feature a number of distinguished international speakers including: Dr Matti Aappro; Dr J.Russell Hoverman and Dr Fergus Macbeth.
The conference’s academic programme has been drawn-up by an academic panel under the Academic Chair, Dr Lee-Ann Jones and all clinical topics discussed will be supported by clinical registry data unique to ICON. It will include an examination of the most prevalent diseases, as well as the most crucial current topics in research.
Parallel sessions for Chemotherapy Nurses and Pharmacists, Oncology Social Workers, Radiotherapists and Medical Physicists and Practice Managers and Administrative Staff will be held. There will also be the launch of the new ICON Best Supportive Care Programme and the ICON Standards, Guidelines and Competencies for Chemotherapy Administration.
So, something for everyone.
A bit more about our international speakers:
DR MATTI AAPRO
Dr Matti Aapro is an expert on breast cancer, cancer in the elderly and supportive care and is based in Switzerland. He will be speaking on topics including new MASCC ESMO antiemetic guidelines, assessing the elderly patient, ABC-3 guidelines in advanced breast cancer and current bone modifying agents in breast cancer.
Dr Aapro was a fellow at the Arizona Cancer Centre in Tucson and was the founding chair of the Medical and Radiation Therapy Department at the European Institute of Oncology in Milan. He is Dean of the Multidisciplinary Oncology Institute in Genolier, serves on the Executive Board of the European Organisation for Research and Treatment of Cancer (EORTC) and was formerly president of the Multinational Association for Supportive Care in Cancer (MASCC).
He was a member of the European Multidisciplinary Cancer Congress 2012 and 2013 Scientific Committees, chaired the scientific organising committees of the International Union Against Cancer’s World Cancer Congress in 2008 and in 2010, and additionally coordinates the SPCC programme of the European School of Oncology.
Dr Aapro is Editor-in-Chief of Critical Reviews in Oncology/Haematology, Associate Editor of Annals of Oncology, and Associate Editor for the geriatric section of The Oncologist. Additionally, he is founding editor of the Journal of Geriatric Oncology.
DR J. RUSSELL HOVERMAN
Dr J. Russell Hoverman works in the fields of value-based cancer care, cancer care pathways and NCCN guidelines. He specialises in medical oncology and is board certified in internal medicine and haematology. His presentation at the ICON conference will look at the continued evolution of pathways, value and the moral weight of our treatment decisions and the oncology care model: using a government defined program for quality care.
Dr Hoverman is the Vice President of Quality Programs for Texas Oncology, P.A. and is the Medical Director of Managed Care for The US Oncology Network and a member of the US Oncology Network Pathways Task Force.
Dr Hoverman presented at the 3rd ICON Conference in Durban 2014, where his contribution to the session on Clinical Pathways by looking at outcomes and value was of enormous practical benefit to ICON over the past few years.
DR FERGUS MACBETH
Dr Fergus Macbeth, a clinical oncologist, will share with us his areas of expertise in clinical guideline development, evidence-based practice and clinical research. He has recently retired from active clinical work, but he had a long-standing interest in lung cancer and has led and participated in a number of important clinical trials. These include the role of heparin in lung cancer.
Dr Macbeth worked for the NHS in England, Scotland and Wales for over 35 years. His career has included a number of years with the National Institute for Health and Care Excellence (NICE) – first as Director of the National Collaborating Centre for Cancer, and later as Director for the Centre for Clinical Practice. He headed the NICE guidelines on melanoma, and is still a mentor to NICE fellows and will be presenting a piece on the “power of guidelines” at the ICON conference, as well as thrombosis and cancer conflicts of interest.
He served as Coordinating Editor for the Cochrane Lung Cancer Review Group, Associate Director of the Wales Cancer Trials Unit in Cardiff, and is Honorary Professor at Cardiff University.
Additionally, he has been a well-known teacher at the UK Cochrane Centre and the Collaboration for Evidence-Based Healthcare in Africa. He obtained his medical training in Oxford and London.
To find out more about the ICON conference on Real-World Oncology or to view the programme and book, please visit the conference website.